CHAPTER 1. Industry Overview of Generative AI in Healthcare Market
1.1. Definition and Scope
1.1.1. Definition of Generative AI in Healthcare
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Generative AI in Healthcare Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Generative AI in Healthcare Market By Application
1.2.3. Generative AI in Healthcare Market By Function
1.2.4. Generative AI in Healthcare Market By End User
1.2.5. Generative AI in Healthcare Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Generative AI in Healthcare Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Generative AI in Healthcare Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Generative AI in Healthcare Market By Application
5.1. Introduction
5.2. Generative AI in Healthcare Revenue By Application
5.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By Application, 2020-2032
5.2.2. Clinical
5.2.2.1. Clinical Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Oncology
5.2.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Cardiovascular
5.2.2.3.1. Cardiovascular Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Infectious Disease
5.2.2.4.1. Infectious Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.5. Dermatology
5.2.2.5.1. Dermatology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.6. Others
5.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. System
5.2.3.1. System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Electronic Health Records
5.2.3.2.1. Electronic Health Records Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Telemedicine
5.2.3.3.1. Telemedicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.4. Disease Diagnosis
5.2.3.4.1. Disease Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.5. Drug Interaction
5.2.3.5.1. Drug Interaction Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Generative AI in Healthcare Market By Function
6.1. Introduction
6.2. Generative AI in Healthcare Revenue By Function
6.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By Function, 2020-2032
6.2.2. AI-Assisted Robotic Surgery
6.2.2.1. AI-Assisted Robotic Surgery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Workflow & Administrative Tasks
6.2.3.1. Workflow & Administrative Tasks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Aid Clinical Judgment/Diagnosis
6.2.4.1. Aid Clinical Judgment/Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Virtual Nursing Assistants
6.2.5.1. Virtual Nursing Assistants Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Image Analysis
6.2.6.1. Image Analysis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Generative AI in Healthcare Market By End User
7.1. Introduction
7.2. Generative AI in Healthcare Revenue By End User
7.2.1. Generative AI in Healthcare Revenue (USD Billion) and Forecast, By End User, 2020-2032
7.2.2. Hospitals & Clinics
7.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Diagnostic Centers
7.2.3.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Healthcare Organizations
7.2.4.1. Healthcare Organizations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Clinical Research
7.2.5.1. Clinical Research Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Others
7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Generative AI in Healthcare Market By Country
8.1. North America Generative AI in Healthcare Market Overview
8.2. U.S.
8.2.1. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.2. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
8.2.3. U.S. Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
8.3. Canada
8.3.1. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.2. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
8.3.3. Canada Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Generative AI in Healthcare Market By Country
9.1. Europe Generative AI in Healthcare Market Overview
9.2. U.K.
9.2.1. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.2. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
9.2.3. U.K. Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Germany
9.3.1. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.2. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
9.3.3. Germany Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. France
9.4.1. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.2. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
9.4.3. France Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
9.5. Spain
9.5.1. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.2. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
9.5.3. Spain Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.2. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
9.6.3. Rest of Europe Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Generative AI in Healthcare Market By Country
10.1. Asia Pacific Generative AI in Healthcare Market Overview
10.2. China
10.2.1. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.2. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.2.3. China Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Japan
10.3.1. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.2. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.3.3. Japan Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. India
10.4.1. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.2. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.4.3. India Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Australia
10.5.1. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.2. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.5.3. Australia Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.6. South Korea
10.6.1. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.2. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.6.3. South Korea Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
10.7.2. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
10.7.3. Rest of Asia-Pacific Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Generative AI in Healthcare Market By Country
11.1. Latin America Generative AI in Healthcare Market Overview
11.2. Brazil
11.2.1. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.2. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
11.2.3. Brazil Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. Mexico
11.3.1. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.2. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
11.3.3. Mexico Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.2. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
11.4.3. Rest of Latin America Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Generative AI in Healthcare Market By Country
12.1. Middle East & Africa Generative AI in Healthcare Market Overview
12.2. GCC
12.2.1. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.2. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
12.2.3. GCC Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
12.3. South Africa
12.3.1. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.2. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
12.3.3. South Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.2. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By Function, 2020-2032
12.4.3. Rest of Middle East & Africa Generative AI in Healthcare Revenue (USD Billion) and Forecast By End User, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Generative AI in Healthcare Market
13.1. Generative AI in Healthcare Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Generative AI in Healthcare Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Syntegra
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Syntegra 2022 Generative AI in Healthcare Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Saxon
14.3. NioyaTech
14.4. Microsoft Corporation
14.5. IBM Watson
14.6. OpenAI
14.7. Google LLC
14.8. Neuralink Corporation
14.9. Tencent Holdings Ltd.
14.10. Johnson & Johnson
14.11. Oracle
14.12. Tencent Holdings Ltd.
The market size of generative AI in healthcare was USD 1.2 Billion in 2022.
The CAGR of generative AI in healthcare is 35.8% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Syntegra, Saxon, NioyaTech, Microsoft Corporation, IBM Watson, OpenAI, Google LLC, Neuralink Corporation, Tencent Holdings Ltd., Johnson & Johnson, Oracle, and Tencent Holdings Ltd.
North America held the dominating position in generative AI in healthcare industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of generative AI in healthcare during the analysis period of 2023 to 2032.
The current trends and dynamics in the generative AI in healthcare industry include increasing demand for personalized medicine, advancements in AI technology and healthcare data analytics, and growing adoption of generative AI for medical imaging and diagnostics.
The medical imaging analysis function held the maximum share of the generative AI in healthcare industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date